TW · Healthcare

Grape King Bio Ltd (1707)

Drug Manufacturers - Specialty & Generic

Grape King Bio Ltd (1707) is listed on TW in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 1707

P/E ratio

18.00

Grape King Bio Ltd (1707) — FAQ

What is 1707's P/E ratio?

The price-to-earnings (P/E) ratio for Grape King Bio Ltd (1707) is 18.00 (data as of 2026-05-23).

Does Grape King Bio Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Grape King Bio Ltd (1707). Check the MyAverix Finance app for the latest dividend data.

What sector is Grape King Bio Ltd in?

Grape King Bio Ltd (1707) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 1707 listed on?

1707 is listed on TW.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)